This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, S. L.
Right arrow Articles by Sachdeva, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, S. L.
Right arrow Articles by Sachdeva, R.
Related Collections
Right arrow Genitourinary Tract
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 107 No. 6 June 2001, pp. 1309-1312

Outcome in Children Receiving Continuous Venovenous Hemofiltration

Received Jul 14, 2000; accepted Sep 28, 2000.

Stuart L. Goldstein*, Helen CurrierDagger , Jeanine M. Graf§, Carmen C. Cosio§, Eileen D. Brewer*, and Ramesh Sachdeva§

From the * Department of Pediatrics, Renal Section, Baylor College of Medicine; Dagger  Texas Children's Hospital Renal Dialysis Unit; and the § Department of Pediatrics, Critical Care Section, Baylor College of Medicine, Houston, Texas.

Objective.  Continuous venovenous hemofiltration (CVVH) alone or with dialysis (D) has become an important supportive therapy for critically ill children with acute renal failure. Previous reports of pediatric patient outcome either mix CVVH/D with other renal replacement modalities or do not examine severity of illness. The current study examines only outcomes of children receiving CVVH/D using Pediatric Risk of Mortality (PRISM) scores to control for severity of illness.

Patients.  Twenty-one patients (mean age: 8.8 ± 6.3 years; mean weight: 28.3 ± 20.8 kg) received 22 courses of CVVH/D.

Outcomes.  Nine (42.8%) of 21 patients survived. Nine (75%) of 12 deaths occurred within 25 days of pediatric intensive care unit (PICU) admission. Mean PRISM score at PICU admission and CVVH initiation were 13.1 ± 5.8 and 15.4 ± 8.9, respectively. Mean patient weight, age, PRISM score at PICU admission and at CVVH/D initiation, maximum pressor number, estimated glomerular filtration rate at CVVH/D initiation and change in mean airway pressure did not differ between survivors and nonsurvivors. The degree of fluid overload at CVVH/D initiation was significantly lower in survivors (16.4% ± 13.8%) compared with nonsurvivors (34.0% ± 21.0%), even when controlled for severity of illness by PRISM score. Mean cost of providing CVVH/D accounted for only 1% of total PICU cost per patient.

Conclusions.  The pattern of early multiorgan system failure and death, minimal relative cost of CVVH/D provision, and potential for improved outcome with initiation of CVVH/D at lesser degrees of fluid overload are factors that may support early initiation of CVVH/D in critically ill children with acute renal failure.  Key words:  continuous venovenous hemofiltration, continuous renal replacement therapy, dialysis, critically ill children.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 CJASNHome page
N. Gibney, E. Hoste, E. A. Burdmann, T. Bunchman, V. Kher, R. Viswanathan, R. L. Mehta, and C. Ronco
Timing of Initiation and Discontinuation of Renal Replacement Therapy in AKI: Unanswered Key Questions
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 876 - 880.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. M. Symons, A. N. Chua, M. J.G. Somers, M. A. Baum, T. E. Bunchman, M. R. Benfield, P. D. Brophy, D. Blowey, J. D. Fortenberry, D. Chand, et al.
Demographic Characteristics of Pediatric Continuous Renal Replacement Therapy: A Report of the Prospective Pediatric Continuous Renal Replacement Therapy Registry
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. Jander, M. Tkaczyk, I. Pagowska-Klimek, W. Pietrzykowski, J. Moll, W. Krajewski, and M. Nowicki
Continuous veno-venous hemodiafiltration in children after cardiac surgery
Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1022 - 1028.
[Abstract] [Full Text] [PDF]

Home page
 Crit Care NurseHome page
S. Dirkes and K. Hodge
Continuous Renal Replacement Therapy in the Adult Intensive Care Unit: History and Current Trends
Crit. Care Nurse, April 1, 2007; 27(2): 61 - 80.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. K. Hothi, C. St George-Hyslop, D. Geary, D. Bohn, and E. Harvey
Continuous renal replacement therapy (CRRT) in children using the AQUARIUSTM
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2296 - 2300.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. M McNutt, M. T Holdsworth, C. Wong, J. D Hanrahan, and S. S Winter
Rasburicase for the Management of Tumor Lysis Syndrome in Neonates
Ann. Pharmacother., July 1, 2006; 40(7): 1445 - 1450.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. S. Kolovos, S. L. Bratton, F. W. Moler, E. L. Bove, R. G. Ohye, R. H. Bartlett, and T. J. Kulik
Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery
Ann. Thorac. Surg., November 1, 2003; 76(5): 1435 - 1441.
[Abstract] [Full Text] [PDF]